3Perkins GH,Green MC,Middleton LP,et al.Medullary breast carcinoma:outcomes and prognosis with the utilization of chemotherapy.J Clin Oncol,2004,22:671.
4Adler DD,Carson PL,Rubin JM,et al.Doppler ultrasound color flow imaging in the study of breast cancer:preliminary findings.Ultrasound Med Biol,1990,16(6):553-559.
5Chao TC,Lo YF,Chen SC,et al.Color Doppler ultrasound in benign and malignant breast tumors.Breast Cancer Res Treat,1999,57(2):193-199.
6Yoshji H,Gomez DE,Shibuya M,et al.Experession of vascular endothelial growth factor,its receptors,and other angiogenic factors in human breast cancer.Cancer Res,1996,56(9):2013-2016.
7Sehgal CM,Argen PH,Rowling SE,et al.Quantitative vascularity of breast masses by Doppler imaging:regional variations and diagnostic implications.J Ultrasound Med,2000,19:427-440.
8Avassoli EF, Devile E. WHO: Pathology&Genetics, tumors of the breast and female genital organs[M]. Lyon: IARC Press, 2003.10.
9Rizzatto G. Towards a more sophisticated use of breast ultrasound[J]. Eur Radiol, 2001, (11):2425-2435.
10Kim AY, Choi BI, Kim TK, et al. Comparison of contrast-enhanced fundamental imaging, second-harmonic imaging and pulse-inversion harmonic imaging[J]. Invest Radiol, 2001, 36(10):582-588.
9Bolan PJ, Nelson MT, Yee D, et al. Imaging in breast cancer: magnetic resonance spectroscopy[ J]. Breast Cancer Res, 2005, 7 : 149-152.
10Fujisawa T, Hirakata Y, Yanagit M, et al. The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer[ J ]. Breast cancer (Tokyo,Japan), 2013, 20 : 18-20.
